Management of Infections in the Critically Ill Patients: a Hands-on Course on Current Challenges and Future Directions, ESCMID Postgraduate Education Course


8 - 9 May 2015, Grado, Italy

Organisers
  • ESCMID Study Group for Infections in Critically Ill Patients (ESGCIP)
  • Società Italiana Di Terapia Antinfettiva, Antibatterica, Antivirale, Antifungina (SITA)
Course Coordinators
  • Matteo Bassetti, Udine, Italy
  • Garyphallia Poulakou, Athens, Greece
  • Jordi Rello, Barcelona, Spain
Course Objectives

The course will present hot topics for physicians treating critically ill patients. The content will be organised roughly as hot topics in epidemiology, prevention, PK/PDs, treatment and development of infections in critically ill patients. A hands-on device will be used and several case reports will be the framework
for discussions.

Course Venue

Grand Hotel Astoria
Via Marina 59
34073 Grado, Italy

www.hotelastoria.it

Target Audience

60 – 120 practicing intensivists and those who manage critically ill patients, but
also infectiologists, clinical microbiologists, internal medicine specialists, surgeons and pharmacists.

CME Accreditation

The organisers of the course will apply for European CME accreditation through EACCME.

Contact Person (Scientific Programme)

Prof Matteo Bassetti
Infectious Diseases
Santa Maria Misericordia Hospital
Piazzale Misericordia 15
33100 Udine
Italy

Phone +39 04 325 59 353
Fax +39 04 325 59 370


Administrative Secretariat

Lucia Citarella
Academy S.r.l.
Via Aosta 4/A
20155 Milano
Italy

Phone +39 028 706 33 70
Fax +39 029 285 32 86

Course Programme

 

Presentations are availabe in the ESCMID Online Lecture Library.

Friday, 8 May 2015

08:30 Welcome: opening remarks. M. Bassetti & J. Rello

Epidemiology and prevention strategies for critically ill patients
08:45 Epidemiology of MDR in the European ICUs: current status and future                    concerns. G. Rossolini
09:15 The role of selective digestive decontamination in the ICU in an era
            of increasing resistance:
           – Pros. L. Silvestri
           – Cons. G. Dimopoulos
10:15 Prevention of VAP: is zero rate feasible? J. Rello
11:00 Coffee break

Management of Gram-positive infections
11:30 Are we ready to treat all MRSA pneumonia with linezolid?
          – Pros. J. Chastre
          – Cons. H. Giamarellou
12:30 Best duration of antimicrobial treatment for staphylococcal infections.
           M. Akova
13:00 Lunch

PK/PD issues for the treatment of critically ill patients
14:00 Practical application of PK/PD and pharmacokinetic variations in patients
            with vasopressors and mechanical ventilation. F. Pea
14:30 Optimising the use of old drugs (colistin, fosfomycin, rifampin) to                              suppress emergence of resistance and minimise toxicity in severe                          infections. G. Poulakou
15:00 TDM, ICU and antimicrobial: one size fits all? J. Roberts

The new problems
15:30 Interpretation of multistage PCR to detect respiratory viruses in                                patients with respiratory failure. G. Poulakou
16:00 Immunocompromised hosts in the ICU: current challenges. F. G. De Rosa
16:30 Elderly patients in the ICU: management and perspectives.
           G. Dimopoulos

Interactive cases
17:00 Approaching severe intra-abdominal sepsis. Suzana Bukovski
17:30 Complicated skin and soft tissue infections. Igor Muzlovic
18:00 Closing remarks of the first day

Saturday, 9 May 2015

Interactive cases on management of Gram-negative infections in the ICU
08:30 Carbapenemases. M. Bassetti
09:00 Acinetobacter. M. Akova
09:30 Pseudomonas. F. Menichetti
10:00 ESBL. M. Tumbarello
10:30 Coffee break

Fungal infections
11:00 Advances in trials in candidaemia. C. Viscoli
11:30 The best antifungal treatment strategy for severe abdominal infections.
           P. Montravers
12:00 Candida, catheter and source control: the infernal trio. M. Bassetti
13:00 Lunch

Anticipating the future
14:00 Antibiotic stewardship:
           – Perspective from the ICU. J. Rello
           – Perspective from outside the ICU. C. Eckmann
14:30 Is it possible to reduce antimicrobial resistance in the era of XDR                             pathogens? H. Giamarellou
15:00 Exploring antivirulence strategies. J. Chastre
16:00 Closing remarks

Faculty Members
  • M. Akova, Ankara, Turkey
  • M. Bassetti, Udine, Italy
  • S. Bukovski, Zagreb, Croatia
  • J. Chastre, Paris, France
  • F. G. De Rosa, Torino, Italy
  • G. Dimopoulos, Athens, Greece
  • C. Eckmann, Peine, Germany
  • H. Giamarellou, Athens, Greece
  • F. Menichetti, Pisa, Italy
  • P. Montravers, Paris, France
  • I. Muzlovic, Ljubljana, Slovenia
  • F. Pea, Udine, Italy
  • G. Poulakou, Athens, Greece
  • J. Rello, Barcelona, Spain
  • J. Roberts, Liverpool, UK
  • G. Rossolini, Florence, Italy
  • L. Silvestri, Gorizia, Italy
  • M. Tumbarello, Rome, Italy
  • C. Viscoli, Genoa, Italy